about
Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogensAn oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.Ontology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network.Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308Importance of Lipopolysaccharide and Cyclic β-1,2-Glucans in Brucella-Mammalian Infections.Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challengeImmunogenic and invasive properties of Brucella melitensis 16M outer membrane protein vaccine candidates identified via a reverse vaccinology approachProtective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.Brucellosis Ontology (IDOBRU) as an extension of the Infectious Disease Ontology.Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in miceCharacterization of outer membrane vesicles from Brucella melitensis and protection induced in mice.Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model.A novel multi-epitope recombined protein for diagnosis of human brucellosis.Immunization with individual proteins of the Lrp/AsnC family induces protection against Brucella melitensis 16M challenges in miceStructural, Functional, and Immunogenic Insights on Cu,Zn Superoxide Dismutase Pathogenic Virulence Factors from Neisseria meningitidis and Brucella abortus.Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.In silico analysis of Brucella abortus Omp2b and in vitro expression of SOmp2b.A history of the development of Brucella vaccines.Brucellosis in low-income and middle-income countries.Immunoreactivity evaluation of a new recombinant chimeric protein against Brucella in the murine model.Confronting the barriers to develop novel vaccines against brucellosis.Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.Brucella suis carbonic anhydrases and their inhibitors: Towards alternative antibiotics?Seroprevalence of Brucellosis among Patients Attending a District Hospital in Rwanda.A review of Brucellosis in Iran: Epidemiology, Risk Factors, Diagnosis, Control, and PreventionA rapid cycleave PCR method for distinguishing the vaccine strain Brucella abortus A19 in China.Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.Species identification and molecular typing of human Brucella isolates from Kuwait.In silico design, cloning and high level expression of L7/L12-TOmp31 fusion protein of Brucella antigens.Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection.A rapid minor groove binder PCR method for distinguishing the vaccine strain Brucella abortus 104M.In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b Antigens.Immunological responses to recombinant cysteine synthase A of Brucella abortus in BALB/c mice.Protective role of specific murine antibodies in inhibiting systemic proliferation of virulent strain 544 in mice and guinea pig
P2860
Q27011190-0BCDC0FB-6965-4041-811D-563062655EF9Q33802696-E20ED0A1-83AD-41E9-B118-BF2BAB044741Q34003852-F875D83F-9248-4F3B-A6F0-27CD4300D8E7Q34199069-8BDDB047-CEC0-443A-BB66-758C0C6076F6Q34373041-1AC11735-422D-4C46-BB20-208BCF11B5B8Q34459329-CF047621-2508-4EEE-983F-BD4F4D3F6F93Q34637943-F0D1D83D-6AD6-4C0F-BD3A-E9ACD165F9BDQ35191851-E49A618D-FB26-478C-9BA0-4D72671C6D82Q35273029-1FD55124-5FEB-443A-8865-9E6C5906AD56Q35555002-7CDF3FD1-400E-47E5-8450-B7DAF36F4DA0Q35592058-95E69A46-245B-48F3-B518-3C35B39D4B1BQ35661526-2EBD0992-B1F8-4983-B7CE-D4EA580C8112Q35739119-57FD31DF-DB71-4C15-BD73-6B9A5ECF6C4AQ36024345-67993D1C-3C02-4430-A0B1-198ECC80982EQ36222924-FA55D6D9-B194-4AB8-AA06-0D470B7A1E3AQ36297476-482F8A5E-CD6F-4129-9C80-B31A7DA31B44Q36396770-D46566A5-9593-47CB-84C1-F3C0DB33C224Q36547983-41EBEE00-B1B9-48AE-A18C-15CCFF105B19Q36938722-70AE8DB7-AAFE-48EC-A305-F1CD6F810053Q37466091-139BAC3B-1162-48A6-A98A-281FDA361C15Q37477950-2497D9E7-C15C-4066-B134-F5861CAA0AEFQ37932521-228C47C9-A881-4F89-8EF0-FD1447137FE1Q38110546-5C277423-E41C-4B65-9111-4B48FA43A8CBQ39168933-729B0F42-7770-482F-ABFB-9A53B5BC9EF6Q40045929-05E2F625-E5F6-407E-B989-F5321DC00802Q40098465-FC09B5E2-B4D3-419A-B61A-5E32D06DE440Q40802051-17FF5357-F90F-4495-A896-B1F6C9B5A7D7Q40978948-6B877756-A5D8-4D68-A1BA-8373D3963B4DQ41363091-FCD87BCA-498A-42F0-831B-8BF2F2DE35D1Q41938593-035FC8AF-F051-4FFD-B67E-962CE84AE268Q43177186-5024F4E3-8B10-4BB2-AB4F-62E3661CF66DQ47163895-1A6FD915-8E28-4F98-8970-F3EAEB131A5CQ48181849-5D0E1DA0-0253-4D18-859A-5AC76E4DE309Q52358100-C0C522F5-4826-4D31-9CAC-4B3AA8542486Q53127737-A77B63C2-BF18-4017-A172-B926530314A8Q57095950-6A8CDF97-F028-49AA-9FE6-E2FAA3E85E35
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Towards a Brucella vaccine for humans.
@ast
Towards a Brucella vaccine for humans.
@en
Towards a Brucella vaccine for humans.
@nl
type
label
Towards a Brucella vaccine for humans.
@ast
Towards a Brucella vaccine for humans.
@en
Towards a Brucella vaccine for humans.
@nl
prefLabel
Towards a Brucella vaccine for humans.
@ast
Towards a Brucella vaccine for humans.
@en
Towards a Brucella vaccine for humans.
@nl
P2093
P1476
Towards a Brucella vaccine for humans.
@en
P2093
Helen S Atkins
Sophie J Smither
Stuart D Perkins
P304
P356
10.1111/J.1574-6976.2010.00211.X
P577
2010-01-19T00:00:00Z